Related Experiment Videos
[Flash visual evoked potentials (FVEP) examination under midazolam sedation of non-cooperating children]
Dorota Pojda-Wilczek1, Ludwik G Stołtny, Stefan M Pojda
1Katedra i Oddział Kliniczny Okulistyki Slaskiej Akademii Medycznej w Katowicach, Szpital Specjalistyczny nr 1 w Bytomiu.
Insights
Midazolam sedation effectively facilitates visual evoked potential (VEP) examinations in uncooperative children. This safe and well-tolerated method improves diagnostic capabilities for pediatric vision assessments.
Area of Science:
- Ophthalmology
- Pediatric Neurology
- Clinical Pharmacology
Context:
- Assessing visual function in non-cooperative children presents significant challenges.
- Visual evoked potential (VEP) testing is crucial for diagnosing visual pathway disorders.
- Sedation is often necessary to obtain reliable VEP results in pediatric populations.
Purpose:
- To determine optimal midazolam maleate sedation conditions for VEP examinations in non-cooperative children.
- To evaluate the efficacy and safety of oral midazolam maleate for pediatric VEP testing.
- To establish the appropriate sedation level for successful VEP acquisition.
Summary:
- A study involving 32 children (8 months–13 years) with behavioral or visual impairments explored midazolam maleate sedation for VEP testing.
- Oral midazolam maleate (0.4-0.5 mg/kg) was administered according to ISCEV standards for flash and bright flash VEP.
- Only 6 children (11 months–3.5 years) required sedation, indicating its targeted use. Midazolam sedation enabled VEP examinations, proving safe and well-tolerated.
Impact:
- Midazolam sedation, achieving a second-degree sedation level on the Ramsey scale, is effective for VEP examinations in non-cooperative children.
- This approach enhances the diagnostic yield of VEP testing in challenging pediatric cases.
- Facilitates earlier and more accurate diagnosis of visual impairments in young children.
Purpose:
To find the optimal conditions for visual evoked potential (VEP) examination of non-cooperative children using midazolam maleate sedation.
Patients:
32 children aged from 8 months to 13 years (mean 3.5 years) with mental disorders, emotional problems and/or very low vision due to various reasons.
Methods:
VEP--flash and bright flash according to ISCEV standards. Midazolam maleate sedation 0.4-0.5 mg per kilo body weight, given orally.
Results:
Only 6 children aged from 11 months to 3.5 years (mean 2.5 years) required sedation for VEP examination. Midazolam sedation unabled VEP examination, was safe for children and well-tolerated.
Conclusion:
Second degree sedation in Ramsey score is effective for good VEP examination of non-cooperative children.